Log in
Enquire now
‌

Collagen Membrane Combined With HUC-MSCs Transplantation in Patients With Nasal Septum Perforation

OverviewStructured DataIssuesContributors

Contents

clinicaltrials.gov/study/NCT02947191
Is a
‌
Clinical study
0

Clinical Study attributes

NCT Number
NCT029471910
Trial Recruitment Size
120
Trial Sponsor
Chinese Academy of Sciences
Chinese Academy of Sciences
0
Clinical Trial Start Date
2016
0
Primary Completion Date
2021
0
Study Completion Date
2021
0
Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Treatment0
Intervention Type
Biological0
Intervention Name
Collagen membrane + HUC-MSCs0
Interventional Trial Phase
Phase 20
Phase 10
Official Name
The Safety and Efficacy Assessment of Collagen Membrane Combined With Human Umbilical Cord Mesenchymal Stem Cells (HUC-MSCs) Transplantation in Patients With Nasal Septum Perforation0
Last Updated
January 5, 2021
0
Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Study summary

The purpose of this study is to assess the safety and efficacy of collagen membrane combined with human clinical grade umbilical cord mesenchymal stem cells(HUC-MSCs) transplantation in patients with chronic nasal septum perforation.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like Collagen Membrane Combined With HUC-MSCs Transplantation in Patients With Nasal Septum Perforation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.